These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16968336)

  • 21. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug consumption rooms: an overdue extension to harm reduction policy in the UK?
    Lloyd C; Hunt N
    Int J Drug Policy; 2007 Jan; 18(1):5-9. PubMed ID: 17689338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public perceptions of public drug use in four UK urban sites.
    Cusick L; Kimber J
    Int J Drug Policy; 2007 Jan; 18(1):10-7. PubMed ID: 17689339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice.
    Moore D; Dietze P
    Drug Alcohol Rev; 2005 May; 24(3):275-84. PubMed ID: 16096131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
    Gustafson DL; Goodyear L; Keough F
    Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK.
    Kimergård A; McVeigh J
    BMJ Open; 2014 Jun; 4(6):e005275. PubMed ID: 24898090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Individual' harms, Community 'harms': reconciling Indigenous values with drug harm minimisation policy.
    van der Sterren AE; Anderson IP; Thorpe LG
    Drug Alcohol Rev; 2006 May; 25(3):219-25. PubMed ID: 16753645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injecting drug user views (and experiences) of drug-related litter bins in public places: a comparative study of qualitative research findings obtained from UK settings.
    Parkin S; Coomber R
    Health Place; 2011 Nov; 17(6):1218-27. PubMed ID: 21865072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The social structural production of HIV risk among injecting drug users.
    Rhodes T; Singer M; Bourgois P; Friedman SR; Strathdee SA
    Soc Sci Med; 2005 Sep; 61(5):1026-44. PubMed ID: 15955404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fine line between harm reduction and harm production--development of a clinical policy on femoral (groin) injecting.
    Zador D; Lintzeris N; van der Waal R; Miller P; Metrebian N; Strang J
    Eur Addict Res; 2008; 14(4):213-8. PubMed ID: 18583919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injecting drug users' experiences of targeted harm reduction in the Russian Federation.
    Power R; Nozhkina N; Kanarsky I
    Drug Alcohol Rev; 2005 Jan; 24(1):69-77. PubMed ID: 16191724
    [No Abstract]   [Full Text] [Related]  

  • 39. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safer groin-injecting interventions are needed and justifiable as part of a harm reduction approach.
    Rhodes T; Kimber J
    Addiction; 2007 Dec; 102(12):1987-8. PubMed ID: 18031433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.